GOTHENBURG, Sweden, August 13, 2003 (PRIMEZONE) -- Nobel Biocare Group (Other OTC:NBCHF) (Stockholm:NOBE):
Strong Sales and Profitability Growth in the Second Quarter
- Revenue was up 19.8% in local currencies in the Second Quarter; 20.6% in local currencies excluding sales of the discontinued Gore products. Profit from operations (EBIT), before restructuring expenses in 2002, increased by 27.6% and amounted to EUR 21.7 million in the Second Quarter 2003.
- In the First Half of 2003, revenue increased by 15.8% in local currencies and amounted to EUR 165.3 million. Excluding sales of the discontinued Gore products, revenue increased in local currencies by 16.3%. Profit from operations (EBIT), before restructuring expenses in 2002, increased by 20.2% and amounted to EUR 41.1 million in the First Half of 2003. In local currencies, EBIT increased by 58.5%.
- Net profit increased by 79.2% to EUR 31.0 million in the First Half of 2003 as a result of the accelerated growth in revenue, tight cost management and the fact that the 2002 comparative figure includes restructuring expenses incurred in 2002.
Further information is available from: Harrieth Sundaeus, Chief Financial Officer, tel. +46 31 81 88 48, +46 708 81 88 48 Gunilla Ekholtz, Investor Relations Officer, tel. +46 31 81 88 36, +46 708 81 88 36
This information was brought to you by Waymaker http://www.waymaker.net
The full report is available for download:
http://www.waymaker.net/bitonline/2003/08/13/20030813BIT00020/wkr0001.doc
http://www.waymaker.net/bitonline/2003/08/13/20030813BIT00020/wkr0002.pdf